160 related articles for article (PubMed ID: 35787702)
41. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy.
Kelley ST; Bloomston M; Serafini F; Carey LC; Karl RC; Zervos E; Goldin S; Rosemurgy P; Rosemurgy AS
Am Surg; 2004 Sep; 70(9):743-8; discussion 748-9. PubMed ID: 15481288
[TBL] [Abstract][Full Text] [Related]
42. [Comparative clinical efficacy analysis of pancreatoduodenectomy for distal bile duct and pancreatic head cancer: a report of 1 005 cases].
Wu PF; Zhang K; Lu ZP; Lin JZ; Chen JM; Xi CH; Wei JS; Guo F; Tu M; Jiang KR; Miao Y
Zhonghua Wai Ke Za Zhi; 2022 Feb; 60(2):128-133. PubMed ID: 35012271
[No Abstract] [Full Text] [Related]
43. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.
Scheuermann U; Kaths JM; Heise M; Pitton MB; Weinmann A; Hoppe-Lotichius M; Otto G
Eur J Surg Oncol; 2013 Jun; 39(6):593-600. PubMed ID: 23611755
[TBL] [Abstract][Full Text] [Related]
44. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?
Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF
Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969
[TBL] [Abstract][Full Text] [Related]
45. Prognostic factors for radical resection of middle and distal bile duct cancer.
Nomura T; Tsuchiya Y; Nashimoto A; Yabusaki H; Takii Y; Nakagawa S; Sato N; Kanbayashi C; Tanaka O
Hepatogastroenterology; 2009; 56(90):294-8. PubMed ID: 19579585
[TBL] [Abstract][Full Text] [Related]
46. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.
Yamashita Y; Taketomi A; Morita K; Fukuhara T; Ueda S; Sanefuji K; Iguchi T; Kayashima H; Sugimachi K; Maehara Y
Anticancer Res; 2008; 28(4C):2353-9. PubMed ID: 18751418
[TBL] [Abstract][Full Text] [Related]
47. Clinical value of additional resection of a margin-positive distal bile duct in perihilar cholangiocarcinoma.
Otsuka S; Ebata T; Yokoyama Y; Mizuno T; Tsukahara T; Shimoyama Y; Ando M; Nagino M
Br J Surg; 2019 May; 106(6):774-782. PubMed ID: 30889275
[TBL] [Abstract][Full Text] [Related]
48. Visceral infiltration of intrahepatic cholangiocarcinoma is most prognostic after curative resection - Retrospective cohort study of 102 consecutive liver resections from a single center.
Bartsch F; Baumgart J; Hoppe-Lotichius M; Schmidtmann I; Heinrich S; Lang H
Int J Surg; 2018 Jul; 55():193-200. PubMed ID: 29803768
[TBL] [Abstract][Full Text] [Related]
49. [Surgical treatment of distal cholangiocarcinoma].
Bahra M
Chirurg; 2021 Sep; 92(9):788-795. PubMed ID: 34232340
[TBL] [Abstract][Full Text] [Related]
50. Carcinoma of the middle bile duct: is bile duct segmental resection appropriate?
Lee HG; Lee SH; Yoo DD; Paik KY; Heo JS; Choi SH; Choi DW
World J Gastroenterol; 2009 Dec; 15(47):5966-71. PubMed ID: 20014461
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
[TBL] [Abstract][Full Text] [Related]
52. Survival benefit of hepatopancreatoduodenectomy for cholangiocarcinoma in comparison to hepatectomy or pancreatoduodenectomy.
Kaneoka Y; Yamaguchi A; Isogai M; Kumada T
World J Surg; 2010 Nov; 34(11):2662-70. PubMed ID: 20607255
[TBL] [Abstract][Full Text] [Related]
53. Long-term outcomes after hepaticojejunostomy for choledochal cyst: a 10- to 27-year follow-up.
Ono S; Fumino S; Shimadera S; Iwai N
J Pediatr Surg; 2010 Feb; 45(2):376-8. PubMed ID: 20152355
[TBL] [Abstract][Full Text] [Related]
54. Pancreatic and duodenal invasion in distal bile duct cancer: paradox in the tumor classification of the American Joint Committee on Cancer.
Ebata T; Nagino M; Nishio H; Igami T; Yokoyama Y; Nimura Y
World J Surg; 2007 Oct; 31(10):2008-15. PubMed ID: 17661132
[TBL] [Abstract][Full Text] [Related]
55. Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study.
Zhang XF; Chakedis J; Bagante F; Beal EW; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
World J Surg; 2018 Mar; 42(3):849-857. PubMed ID: 28879598
[TBL] [Abstract][Full Text] [Related]
56. [Carcinomas of the distal bile duct].
Bahra M; Langrehr JM; Neuhaus P
Chirurg; 2006 Apr; 77(4):335-40. PubMed ID: 16523255
[TBL] [Abstract][Full Text] [Related]
57. Endoscopic stenting in bile duct cancer increases liver volume.
Lee CH; Kim SH; Kim IH; Kim SW; Lee ST; Kim DG; Yang JD; Yu HC; Cho BH; Lee SO
Gastrointest Endosc; 2014 Sep; 80(3):447-55. PubMed ID: 24679659
[TBL] [Abstract][Full Text] [Related]
58. Prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy.
Lyu S; Li L; Zhao X; Ren Z; Cao D; He Q
World J Surg Oncol; 2020 Oct; 18(1):262. PubMed ID: 33032609
[TBL] [Abstract][Full Text] [Related]
59. Efficacy of surgical management for recurrent intrahepatic cholangiocarcinoma: A multi-institutional study by the Okayama Study Group of HBP surgery.
Kojima T; Umeda Y; Fuji T; Niguma T; Sato D; Endo Y; Sui K; Inagaki M; Oishi M; Ota T; Hioki K; Matsuda T; Aoki H; Hirai R; Kimura M; Yagi T; Fujiwara T
PLoS One; 2020; 15(9):e0238392. PubMed ID: 32881910
[TBL] [Abstract][Full Text] [Related]
60. Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy.
Natsume S; Ebata T; Yokoyama Y; Igami T; Sugawara G; Shimoyama Y; Nagino M
Ann Surg; 2012 Apr; 255(4):754-62. PubMed ID: 22367444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
